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Oesophageal carcinoma (OC) is highly prevalent in Western Kenya especially among the members of the Kalenjin
community who reside in the Northern and Southern areas of the Rift Valley. Previous authors have suggested
potential association of environmental and genetic risk factors with this high prevalence. The environmental factors
that have been suggested include contamination of food by mycotoxins and/or pesticides, consumption of
traditional alcohol (locally referred to “Busaa” and “Chan’gaa”), use of fermented milk (“Mursik”), poor diet, tobacco
use and genetic predisposition. The aim of this paper is to critically examine the potential contribution of each of
the factors that have been postulated to be associated with the high prevalence of the disease in order to establish
the most likely cause. We have done this by analyzing the trends, characteristics and behaviours that are specifically
unique in the region, and corroborated this with the available literature.
From our findings, the most plausible cause of the high incidence of OC among the Kalenjin community is
mycotoxins, particularly fumonisins from the food chain resulting from poor handling of cereals; particularly maize
combined with traditional alcohol laced with the toxins interacting synergistically with other high-risk factors such
as dietary deficiencies associated alcoholism and viral infections, especially HPV. Urgent mitigating strategies should
be developed in order to minimize the levels of mycotoxins in the food chain.
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Oesophageal carcinoma (OC) is the sixth cause of cancer
related mortality, and the eighth most common cancer
globally. It is more common among men, and associated
with older age [1–3]. There are two histological types;
oesophageal adenocarcinoma (OAC) which presents in
the lower part of the oesophagus, and oesophageal
squamous-cell carcinoma (OSCC) which tends to be on
the upper and middle part, and arises from epithelial
cells that line the oesophagus [4–8]. Several predisposing
risk factors for OC have been reported [9–11]. The risk
factors that have been reported for OSCC include tobacco
smoking and consumption of alcohol [12–14], consump-
tion of hot food and beverages [15–18], including “Mate”, a
tea-like nonalcoholic infusion from Ilex paraguariensis* Correspondence: kigengfk@gmail.com
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(http://creativecommons.org/publicdomain/zeplant [19, 20] and poor diet [10]. The main risk factors that
have been reported to predispose OAC include gastro-
esophageal reflux disease, obesity, smoking, aging, diet and
radiation therapy [5, 14, 21–24]. Factors known to protect
against adenocarcinoma development include Helicobacter
pylori infection, a diet rich in fruits and vegetables, and use
of aspirin and other non-steroidal anti-inflammatory agents
[10, 25, 26]. The role of human papilloma virus (HPV), an
oncogenic virus is still debatable [27]. Some researchers
have concluded that it may have a role in the OSCC car-
cinogenesis based on meta-analytic reviews [28–30], while
others have concluded that it has no direct role [31–33].
Authors from a recent publication have also provided
evidence of the lack of HPV association based on molecular
biology criteria [34]. In addition, recent genomic studies
obtained from sequencing OSCC samples collected from
sub-Saharan Africa (SSA), suggest that the endemic nature
of the disease is due exposure to a carcinogen other than
tobacco and oncogenic viruses [35].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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prevalent in developed world; and OSCC in low and
middle income countries (LMICs) with Eastern and
Southern Africa, as well as Eastern Asia recording the
highest prevalence [1, 8, 14, 36–38]. It has also been re-
ported to be more prevalent in black men [39–41]. This
has largely been attributed to poor diet/dietary deficien-
cies, alcohol consumption and tobacco smoking, expos-
ure to mycotoxin metabolites (aflatoxins and fumonisins
in particular) and HPV infection, especially in SSA [37,
42–45]. Interestingly, authors from a fairly recent re-
search paper have reported the age-standardized inci-
dence rates of OSCC in East Africa to be higher than
the mean world rates, suggesting that the incidence in
the region may be higher than initially postulated [46].
Currently, it is difficult to get accurate national data on
the prevalence of OC in Kenya because there only two
cancer registries, one based in the capital Nairobi
(Nairobi Cancer Registry [NCR]) and the other in
Eldoret (Eldoret Cancer Registry) which is located in the
Western region respectively [47, 48]. Data from NCR
have reported OC to be the second most diagnosed can-
cer in men (8.9%) after prostate, and third in women
(4.9%), after breast and cervical [49]. A new report from
NCR classifying cancer risk as per ethnic group still has
OC as the third most frequent [50].
However, OSCC has been reported to occur more fre-
quently in Western Kenya, and more significantly among
the members of the Kalenjin community who reside in
the Northern and Southern areas of the Rift Valley [51–
58]. Five-year data from Eldoret Cancer Registry regarding
cancer prevalence in Uasin Gishu County, an area resided
mainly by the Kalenjins shows OC to be the most com-
mon cancer. It is most prevalent among men followed by
leukemia and prostate, whereas it is third most common
in women after cervix and breast [48]. It has been re-
ported to literally occur in all the age groups, with OSCC
situated at the middle third portion of the oesophagus be-
ing the commonest histological type [53, 54, 56, 57, 59].
Previous authors have suggested potential association of
environmental and genetic risk factors with this high
prevalence. The environmental factors that have been sug-
gested include consumption of traditional alcohol (locally
referred to “Busaa” and “Chan’gaa”), use of fermented
milk (“Mursik”), poor diet and exposure to mycotoxins
and nitrosamines [37, 54, 57, 60–62].
The North and Southern parts of Rift Valley comprise
an important agricultural area in Kenya. Indeed, it has
been dubbed at the “bread basket” of the country. The
Kalenjin constitute the largest community residing in the
region, with Kalenjin sub-tribes of Nandi, Keiyo and Mar-
akwet living in the northern part; while the Kipsigis and
their Maasai cousins residing in the southern part. The
Luhya community is mainly found in the neighbouringregion (formerly referred to as Western Province), and
some parts of the North rift. Naturally, the main activity
in the region is farming, in both small and large scales. A
type of stiff porridge made by mixing cornmeal with boil-
ing water, commonly referred to as “Ugali” is the most
popular dish in the area; and is mainly consumed with
vegetables, and occasionally meat for those who can afford
[63, 64]. This is usually combined with milk, either fresh
or fermented (“Mursik”) among the Kalenjin [65]. Alco-
holism is rampant especially in the rural areas, with the
most popular drink being traditional brews, either “Busaa”
or “Chan’gaa” [66, 67]. Incidentally, this is the region that
unusually bears one of the highest brunts of OC in the
world, especially among the Kalenjin community [46, 48,
52–54, 57, 58]. We have critically examined the potential
contribution of each of the factors that have been postu-
lated to be associated with the high prevalence of the dis-
ease in order to establish the most likely cause. We did
this by analyzing the trends, characteristics and behaviours
that are specifically unique in the region, and corroborated
this with the available literature. These include the roles of
contamination of food by mycotoxins and/or pesticides,
consumption of traditional alcoholic brews and “Mursik”,
tobacco use, genetic predisposition and HPV infection.Mycotoxins
Mycotoxins are toxic metabolites produced by fungi that
normally contaminate agricultural cereals, either in the
field, during harvest or storage; and are mainly associated
with cereal crops, including maize, wheat, barley, rice and
oats. They are common throughout the world, and myco-
toxin contamination of food is now considered a serious
public health problem, especially in SSA [68, 69]. They in-
clude aflatoxins, fumonisins, zearalenone, moniliformin,
ochratoxins, trichothecenes, deoxynivalenol, diacetoxys-
cirpenol, and nivalenol [43, 70, 71]. Aspergillus flavus and
Aspergillus parasiticus which are abundant in warm and
humid regions are the main aflatoxin producing group of
fungi, whereas fumonisins and trichothecenes are mainly
produced by Fusarium verticillioides and F. proliferatum
[45, 72–74]. Mycotoxins metabolites have been associated
with the development of several diseases including aflatox-
icosis, hepatotoxicity, neural tube defects, immunosup-
pression, infertility, haematotoxicity, growth impairment
and cancer [74–78]. The metabolites that have been de-
scribed to induce oncogenesis include fumonisins and af-
latoxins, which have both been associated with the
development of oesophageal and hepatocellular carcinoma
[HCC] [79]. Most of the current publications however
tend to associate aflatoxins more with HCC, whereas
fumonisins are linked to the development of both malig-
nancies [80–83]. Additionally, fumonisins have been asso-
ciated with renal carcinoma [84, 85].
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Fumonisin B1 (FB1) is the most prevalent member of
fumonisin family of toxins, and its link to the develop-
ment of OC has been known for a long time; having
been implicated in the high incidence of OC in China
and South Africa in the 90s [76, 81, 86–88]. It is also a
known hepatocarcinogen that causes HCC [82, 83, 87–
89]. The mechanisms for carcinogenesis are still uncer-
tain. It is however thought to be nongenotoxic (non-
DNA reactive), and several mechanisms have been pos-
tulated for its oncogenesis. These include possible role
of oxidative damage during initiation and disruption of
lipid metabolism, integrity of cellular membranes and al-
tered growth-regulatory responses [78, 83, 88]. FB1 has
been demonstrated to be nongenotoxic in bacterial mu-
tagenesis screens or unscheduled DNA-synthesis assays
[84, 90]. Previous researchers have concluded that it
produces oncogenesis through apoptotic necrosis, atro-
phy, and consequent regeneration as a result of ceramide
synthase inhibition and disruption of sphingolipid me-
tabolism [82–84, 90–92]. FB1 bears a structural similar-
ity to the cellular sphingolipids, thereby disturbing the
metabolism of sphingolipids by inhibiting ceramide syn-
thase enzyme leading to accumulation of sphinganine in
some cells and tissues thus inducing apoptosis, especially
in the liver cells. The ability of FB1 to accumulate
sphingosine or sphinganine and arrest the cell cycle in
selected cells is thought to play an important role in the
carcinogenesis or disease [78, 88, 93].Aflatoxins
Aflatoxins are known human carcinogens that have been
demonstrated to participate in the pathogenesis of HCC,
with aflatoxin B1 (AFB1) being the most dominant and po-
tent aflatoxinin [80, 81, 94, 95]. AFB1 in conjunction with
hepatitis B virus has been associated with the development
of HCC in resource limited countries [72, 85, 96–100]. In
addition, the toxic effects of aflatoxins on immunity and
nutrition combine to negatively affect health factors in-
cluding HIV infection which accounts for a high percent-
age of the burden of disease in developing countries [80,
94]. Indeed, the dietary exposure to aflatoxins has been
touted as an important contributor to the high incidence
of HCC in Asia and SSA, where almost 82% of the world-
wide cases occur [97, 101–103]. The exact mechanism is
not yet very clear, but it is thought to be through conver-
sion of aflatoxin B1 to aflatoxin B1 formaminopyrimidine,
a mutagenic and carcinogenic adduct metabolite that acts
synergistically hepatitis B virus to generate mutations of
the tumour suppressor genes thus resulting in hepatocel-
lular carcinoma [104–108]. Additionally, aflatoxin con-
tamination has also been described as risk factor for
esophageal cancer [109].Mycotoxin contamination
There are many published reports about mycotoxin con-
tamination, and its toxic metabolites in Kenyan cereals, par-
ticularly maize [60, 61, 110–117]; including outbreaks
[118–120]. This has largely been associated with delayed
and poor harvesting methods, drying and storage in defi-
cient or inappropriate facilities [115, 116, 119, 121, 122].
Mycotoxins have also been detected in food including meat,
milk and eggs; as well as in traditional beer. This has been
attributed to contaminated livestock feeds and maize flour
used in the fermentation of “Busaa” [123, 124].
Taking Uasin Gishu County in the North Rift as a case
in point, the rise in mycotoxin contamination, can be
historically traced to failed agricultural policies and
diminishing Government support over the years [125,
126]. The Kalenjin are pastoral by nature, but during the
colonial period (up to late1950s), they like every other
indigenous Africans were confined to tribal homelands
commonly referred to as “reserves”, where they practiced
peasant farming. They grew finger millet and maize
(“Cheborosinik”) introduced earlier by the British & Por-
tuguese, that was just enough for subsistence, and sup-
plemented with dairy products [63, 65, 127, 128]. The
maize was well dried and stored in small barns, thereby
exposing the cereal to very low levels of contamination
[129–132]. After Independence (1961-1976), land was
distributed and the farmers adopted higher yielding var-
ieties of maize and wheat which led to a significant in-
crease in agricultural production. The cereals were
marketed by a farmer’s organization named the Kenya
Farmers Association (KFA) under strict regulations by
both the Ministry of Agriculture and Maize and Produce
Board [125, 126]. The farmers were also cushioned by a
seasonal credit insurance system (Guaranteed Minimum
Returns), in case of any crop failures mainly due chan-
ging weather patterns. There was therefore little con-
tamination, or the contaminated products were
destroyed before reaching the market [127, 133, 134].
Since the introduction of liberalization of maize produce
in 1987/88, farmers have had to endure with a lot of chal-
lenges including deregulation of prices, low producer prices,
low quality inputs, weather variability, elimination of subsid-
ies, disincentives for production, including inefficiencies in
marketing, reduction in the acreage and several other prob-
lems [122, 126, 134, 135]. In addition, there has been signifi-
cant importation of cheap maize over the years, thus
dampening the local prices. The ever-changing weather pat-
tern and lack of storage facilities coupled with the high cost
of drying has exacerbated the problem. This has led to pov-
erty and poor management of the crop, with farmers adopt-
ing poor methods of handling the produce in order to
decrease the costs of production. The farmers now tend to
dry their maize in open spaces in urban areas when rejected
by the millers due to high moisture content, whereby they
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posing the grain to further contamination [136] (Fig. 1). In
addition, the rotten pieces are no longer discarded but are ei-
ther converted to animal feeds or milled and sold to “Busaa”
brewers [123, 125, 137–139]. This directly introduces myco-
toxins to the food chain, either through consumption of
“Ugali” and milk (both staple diets among the Kalenjin),
meat, eggs and other animal products as well as “Busaa” [60,
123, 124]. This is evinced by the reports from the region of
unacceptably high levels of mycotoxins and its metabolites in
stored maize [61, 110–112], and more disturbingly, including
milled maize samples [60]. In some instances, the extent of
contamination is so high that sorting the harvested maize to
remove those with moulds did not reduce the mycotoxin
content [114]. High levels of aflatoxin contamination have
even been detected in human serum, and this has been cor-
related with the level of poverty [140, 141]. With regards to
“Busaa”, a very popular traditional drink in the region [66], it
is apparent that the content of mycotoxin and its metabolites
would be high in most samples, based on the rampant use of
flour from rotten maize for fermentation. Studies conducted
in the region have reported as such [124, 139]. However, re-
lated studies have reported that commercial beer have very
low mycotoxin toxicity confirming the fact that the farmers
tend to supply millers with clean maize because of stringent
requirements by the millers, but select the rotten pieces to
be sold to “Busaa” brewers who are not regulated by author-
ities [137, 142]. We hypothesize that mycotoxin (especially
fumonisin type) contamination of food and alcohol is one of
the most likely causes of the high prevalence rates of
oesophageal, hepatic and related cancers in Western Kenya.
Alcohol consumption and tobacco smoking
The association between consumption of alcohol and to-
bacco smoking with the development of OC, especially
OSCC has been known for a long time [13, 23, 143–145].Fig. 1 Drying maize in the openIndeed, they have both been listed as major contributors
of OSCC in SSA [42]. They are thought to interact syner-
gistically in the development of OC, and some researchers
have even reported a 35-fold increase in the risk resulting
combined use of alcohol, tobacco and marijuana [146–
149]; and up to 50-fold in heavy smokers and drinkers
compared to those who do not drink or smoke [13].
The pathophysiology of alcohol in OSCC is believed to
involve acetaldehyde, a toxic ethanol metabolite which is a
recognized carcinogen. In addition, ethanol itself stimu-
lates carcinogenesis by inhibiting DNA methylation and
by interacting with retinoid metabolism [150–152]. Poly-
morphisms involving alcohol and aldehyde dehydrogen-
ase, the enzymes that metabolize ethanol have therefore
been associated with increased risk. The genotypes that
have been identified from several studies are alcohol
dehydrogenase-1B (encoded by the ADH1B gene) and al-
dehyde dehydrogenase-2 (encoded by ALDH2) respect-
ively. Carriers of these polymorphic genes are discouraged
from taking alcohol based on studies conducted in Asia
[153–158]. To date there is scant information from the lit-
erature about related genetic studies that have been con-
ducted on Africans; despite the reportedly higher
prevalence on OSCC among African-Americans, espe-
cially those who use alcohol and tobacco [39, 40]. Com-
bination of tobacco and alcohol consumption further
increases the risk of OSCC [146, 147, 159, 160]. The mo-
lecular mechanisms by which tobacco induces cancer is
postulated to be mediated through the exposure of
tobacco-specific carcinogenic nitrosamines; 4-(methylni-
trosamino)-1-(3-pyridyl)-1-butanone (NNK) and N'-nitro-
sonornicotine [NNN] [161]. NNK and NNN initiate
tumours through a two-fold synergistic process; deleteri-
ous mutations in oncogenes and tumor suppression genes
resulting in DNA adducts, as well as enhancement of the
tumour growth. The nitrosamines promote tumour
growth by binding to the nicotinic acetylcholine receptors
and stimulating the deregulation of cell proliferation, sur-
vival, migration and invasion which provides an enabling
environment for the proliferation [161–164].
Members of the Kalenjin community are not heavy to-
bacco smokers, but their rampant consumption of trad-
itional alcohol (“Busaa” and “Chan’gaa”) laced with
mycotoxins could be a potential trigger of OSCC.
Traditional fermented milk (“Mursik”)
Fermented milk is part and parcel of Kalenjin culture, and is
usually drunk after every meal. Some have even hypothesized
that their world-class athletic prowess is associated with the
use of “Mursik” [165]. Its preparation process involves the
use of a gourd (“Sotet”), a bow shaped stick (“Sosiot”) usually
from palm trees and charcoal from selected trees and shrubs
(“Suteiywo”), the commonest being Senna didymobotrya,
Juniperus procera, Plectranthus barbatus, Olea europaea and
Kigen et al. Infectious Agents and Cancer  (2017) 12:59 Page 5 of 11wattle trees. The sticks are used to grind embers of the char-
coal by pressing against the walls of a gourd in a methodical,
circular in and out movement of the hand until the inside of
the gourd is evenly covered with fine dust. Boiled milk is
then poured into the gourd and allowed to ferment in cool
dry conditions. If a new gourd is used, then it has to be first
“sweetened” in order remove the bitter taste. This is done by
the use of fresh bark from either Ozoroa insignis, Pappea
capensis or Ficus thonningii. The bark is placed inside the
gourd which is then filled with water and left to cure for
three days [166].
The association of fermented milk including “Mursik”
with oncogenesis is inconclusive [167–172]. From the
literature, the publications that link this mainly relate to
presence of acetaldehyde, a carcinogenic substance in
sour milk and other contaminants as a result of poor
processing [62, 173–175]. Indeed, most of the publica-
tions correlating the prevalence in OSCC among the
Kalenjin community to the consumption of “Mursik”
have postulated as such, but there is no direct relation-
ship from literature [54, 58, 62]. In any case, the amount
of acetaldehyde from fermented milk may not be as high
as the amount from alcohol per se. The most plausible
association between “Mursik” with OSCC would there-
fore emanate from “Mursik” containing mycotoxins ori-
ginating from contaminated animal feeds; which would
act synergistically with acetaldehyde present in the fer-
mented milk [60, 70, 123, 124, 138, 176]. Further re-
search should be conducted to determine the levels of
mycotoxins and aldehydes in “Mursik”.
Pesticides and herbicides
Being an agricultural region, there is widespread use of
pesticides and herbicides in the Rift Valley. From the lit-
erature, there are several publications linking the use of
these chemicals with potential development of several
types of cancers [177–179]. Most of these reports however
are based on anecdotal evidence and are largely inconclu-
sive, often requiring more studies for definitive conclu-
sions [180–186]. Nevertheless, most of the research that
has been conducted to date have reported the absence of
association between pesticide use and OC [187–189]. Of
note however, is a report by some researchers about a stat-
istical correlation between pesticide use among agricul-
tural workers and development of some forms of cancer
later on in life, including OSCC [190].
Genetic predisposition
To date, there is no specific gene that has been specific-
ally identified whose overexpression will lead to develop-
ment of OC, although many genes and miRNAs
including p53, VEGF, cyclin D1, and miR-21 are consid-
ered useful when predicting the prognosis of EC [191–
194]. The predisposition to OSCC is mainly associatedwith life style risk factors including smoking and alcohol
use, and specifically on the polymorphisms in the en-
zymes involved in metabolism of alcohol acting synergis-
tically with nitrosamines from exposure to tobacco [146,
150, 155, 195]. Genetic polymorphisms of the genes en-
coding alcohol dehydrogenase-1B (ADH1B), aldehyde
dehydrogenase-2 (ALDH2) and cytochrome P4502E1
(CYP2E1) are known to affect the metabolism of alcohol
among the Asian populations [153, 154, 158, 196–198].
Indeed, polymorphism in ADH1B and ALDH2 in com-
bination with tobacco by-products have been demon-
strated to increase the risk of OSCC by up to 190 times
in Japanese population, and predisposition to OSCC
[160]. Carriers of these polymorphic genes are therefore
discouraged from taking alcohol [10, 156, 159]. Unfortu-
nately, there is scant information from the literature
about studies on the impact of these polymorphisms
among the Africans despite the reportedly, unusually
high incidents of OSCC among the African-American
users of alcohol compared to other races [39, 40].
Human Papillomavirus Infection
HPV infection has for a long time been postulated to be
a potential causative agent in the etiology of OC [199].
Despite the fact the hypothesis regarding the link has
been controversial and inconclusive [32, 33, 200, 201],
there are several reports to date associating the etiology
of OC with HPV virus [27, 202–206], especially in high
incidence geographical regions [30, 207–211]. The
mechanism of oncogenesis has is thought to be through
the inactivation of tumour suppressor genes. HPV, par-
ticularly 16 and 18 subtypes has been described to inter-
act with p53 and Rb tumour suppressor proteins leading
to their loss of function. In addition, HPV-16 E6 has
been demonstrated to down-regulate miR-125b, thus ac-
tivating the Wnt/beta-catenin signaling pathway which
promotes tumorigenesis [212, 213]. Despite the Kenya
being in the HPV high risk geographical region, results
from a research conducted from samples collected in
MTRH suggest that HPV may not play a role in the
pathogenesis of OSCC [214]. However, we cannot com-
pletely rule out the role of HPV on the oncogenesis of
OSCC in the region.
Conclusions
The most plausible cause of the high incidence of
oesophageal cancer in Western Kenya, especially among
the Kalenjin community is mycotoxins, particularly fumoni-
sins from the food chain combined with traditional alcohol
laced with the toxins interacting synergistically with other
high-risk factors such as dietary deficiencies associated al-
coholism. Genetic predisposition and HPV-infection may
also contribute. , Further research (including population-
based case-control studies) should be undertaken to
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latory authorities to eliminate or minimize the levels of my-
cotoxins in the food chain. Urgent mitigating strategies
should be developed in order to stem the public health
problems arising from the toxins. These include public edu-
cation to create awareness on the health risks caused by
mycotoxins, and enforcement of strict agricultural mea-
sures in handling the cereals to minimize contamination.
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